About
Kamari Pharma is a biopharmaceutical company developing proprietary small molecule inhibitors of TRPV3, a cation channel primarily expressed in keratinocytes, targeting dermatological conditions with unmet medical needs.
Explore Kamari Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.